| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 11 |
| 1 | ADALIMUMAB | 8 |
| 2 | PREDNISONE | 7 |
| 3 | RITONAVIR | 6 |
| 4 | RITONAVIR 100 MG | 6 |
| 5 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 5 |
| 6 | ENTECAVIR | 5 |
| 7 | ENTECAVIR ANHYDROUS | 5 |
| 8 | MESALAMINE | 5 |
| 9 | OXALIPLATIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SECNIDAZOLE | 1 | 0.0035 |
| 1 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 5 | 0.0004 |
| 2 | ENTECAVIR | 5 | 0.0004 |
| 3 | RITONAVIR 100 MG | 6 | 0.0004 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0003 |
| 5 | ACARBOSE | 1 | 0.0003 |
| 6 | FRUQUINTINIB | 1 | 0.0003 |
| 7 | VONOPRAZAN FUMARATE | 2 | 0.0002 |
| 8 | CALCIUM FOLINATE | 1 | 0.0002 |
| 9 | CAPTOPRIL | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 3 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 4 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 6 | 0.0001 |
| 8 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |